XML 97 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK
AND STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Convertible preferred stock beginning balance (in shares) at Dec. 31, 2020 19,074      
Convertible preferred stock beginning balance at Dec. 31, 2020 $ 182,609      
Increase (Decrease) in Temporary Equity [Roll Forward]        
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering (in shares) (19,074)      
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering $ (182,609)      
Convertible preferred stock ending balance (in shares) at Dec. 31, 2021 0      
Convertible preferred stock ending balance at Dec. 31, 2021 $ 0      
Beginning balance (in shares) at Dec. 31, 2020   12,794    
Beginning balance at Dec. 31, 2020 (80,691) $ 1 $ 30,087 $ (110,779)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]        
Issuance of common stock in connection with initial public offering, net of underwriting discounts and issuance costs (in shares)   4,466    
Issuance of common stock in connection with the initial public offering, net of underwriting discounts and issuance costs 426,192 $ 1 426,191  
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering (in shares)   19,074    
Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering 182,609 $ 2 182,607  
Stock-based compensation expense 40,804   40,804  
Stock options exercised (in shares)   1,882    
Stock options exercised 12,480   12,480  
Common stock repurchased and retired (in shares)   (23)    
Common stock repurchased and retired (868)   (868)  
Options repurchased (7,335)      
Release of restricted stock units (in shares)   79    
Net income (loss) (60,135)     (60,135)
Ending balance (in shares) at Dec. 31, 2021   38,272    
Ending balance at Dec. 31, 2021 513,056 $ 4 683,966 (170,914)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]        
Stock-based compensation expense 73,820   73,820  
Stock options exercised (in shares)   1,739    
Stock options exercised 14,776   14,776  
Release of restricted stock units (in shares)   350    
Net income (loss) (59,574)     (59,574)
Ending balance (in shares) at Dec. 31, 2022   40,361    
Ending balance at Dec. 31, 2022 542,078 $ 4 772,562 (230,488)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]        
Stock-based compensation expense 95,221   95,221  
Release of performance stock units (in shares)   180    
Taxes paid related to net-share settlements of share-based compensation awards ( in shares)   (84)    
Taxes paid related to net-share settlements of share-based compensation awards $ (11,482)   (11,482)  
Stock options exercised (in shares) 1,396 1,396    
Stock options exercised $ 13,617   13,617  
Release of restricted stock units (in shares)   673    
Net income (loss) 16,067     16,067
Ending balance (in shares) at Dec. 31, 2023   42,526    
Ending balance at Dec. 31, 2023 $ 655,501 $ 4 $ 869,918 $ (214,421)